We are live on ! Find out more

Medical Devices
Stocks Ranked by
Market Capitalization

Name Market cap Price Price
change %
ABT icon
1
Abbott
ABT
$179B
$179B $103.44 1.37%
MDT icon
2
Medtronic
MDT
$121B
$121B $94.25 0.57%
SYK icon
3
Stryker
SYK
$116B
$116B $302.64 1.14%
BSX icon
4
Boston Scientific
BSX
$65.4B
$65.4B $45.13 0.99%
EW icon
5
Edwards Lifesciences
EW
$51.9B
$51.9B $90.11 0.5%
GEHC icon
6
GE HealthCare
GEHC
$32.2B
$32.2B $71.24 1.03%
DXCM icon
7
DexCom
DXCM
$29.5B
$29.5B $78.25 0.41%
PHG icon
8
Philips
PHG
$25.9B
$25.9B $26.46 0.41%
STE icon
9
Steris
STE
$22.4B
$22.4B $229.28 0.37%
ZBH icon
10
Zimmer Biomet
ZBH
$18.5B
$18.5B $96.75 0.71%
PEN icon
11
Penumbra
PEN
$12.8B
$12.8B $324.68 0.17%
SNN icon
12
Smith & Nephew
SNN
$12.6B
$12.6B $30.20 0.89%
GKOS icon
13
Glaukos
GKOS
$10.9B
$10.9B $184.77 3.65%
GMED icon
14
Globus Medical
GMED
$10.8B
$10.8B $80.62 1.48%
PODD icon
15
Insulet
PODD
$10.2B
$10.2B $147.21 1.37%
BIO icon
16
Bio-Rad Laboratories Class A
BIO
$10B
$10B $375 0.69%
TXG icon
17
10x Genomics
TXG
$9.7B
$9.7B $74.73 2.43%
BRKR icon
18
Bruker
BRKR
$8.94B
$8.94B $58.69 0.79%
HAE icon
19
Haemonetics
HAE
$5.39B
$5.39B $118.49 0.59%
LIVN icon
20
LivaNova
LIVN
$4.44B
$4.44B $80.63 0.01%
ITGR icon
21
Integer Holdings
ITGR
$4.3B
$4.3B $126.55 0.02%
IRTC icon
22
iRhythm Holdings
IRTC
$3.98B
$3.98B $120.81 0.92%
NEOG icon
23
Neogen
NEOG
$2.71B
$2.71B $12.40 1.56%
TMDX icon
24
Transmedics
TMDX
$2.45B
$2.45B $70.65 0.03%
UFPT icon
25
UFP Technologies
UFPT
$2.25B
$2.25B $290.59 0.24%
1
2 3 4 5

Medical Devices Stocks at a Glance

Medical device companies develop surgical equipment, implants, pacemakers, imaging systems, and other therapeutic machines. Procedure volumes drive recurring demand, with regulatory approvals and surgeon adoption creating high switching costs and durable franchises around installed bases.

There are 136 Medical Devices industry stocks tracked by Wall St. Rank, worth a combined $817B.

The largest by market cap are Abbott (ABT) at $179B, Medtronic (MDT) at $121B and Stryker (SYK) at $116B.

Among institutional investors, Alamar Biosciences (ALMR) drew the most net new fund positions in Q2 2026: 87 funds opened new positions.

Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q2 2026.